tiprankstipranks
Aurinia Pharmaceuticals (DE:IKAP)
NASDAQ:IKAP
Germany Market

Aurinia Pharmaceuticals (IKAP) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Sell
8Bullish
2Neutral
12Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Aurinia Pharmaceuticals’s (IKAP) Moving Averages Convergence Divergence (MACD) indicator is -0.17, suggesting Aurinia Pharmaceuticals is a Buy.
Aurinia Pharmaceuticals’s (IKAP) 20-Day exponential moving average is 13.75, while Aurinia Pharmaceuticals’s (IKAP) share price is €13.53, making it a Sell.
Aurinia Pharmaceuticals’s (IKAP) 50-Day exponential moving average is 13.73, while Aurinia Pharmaceuticals’s (IKAP) share price is €13.53, making it a Sell.

Aurinia Pharmaceuticals (IKAP) Pivot Points

Jul 26, 2026, 01:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.48
13.48
13.48
13.48
13.48
13.48
13.48
Fibonacci
13.48
13.48
13.48
13.48
13.48
13.48
13.48
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aurinia Pharmaceuticals (IKAP) Moving Averages

Jul 26, 2026, 01:47 PM
Period
Simple
Exponential
MA5
13.41Sell
13.39Sell
MA10
13.62Sell
13.56Sell
MA20
13.85Sell
13.75Sell
MA50
13.75Sell
13.73Sell
MA100
13.37Sell
13.39Sell
MA200
12.85Buy
12.63Buy
Aurinia Pharmaceuticals’s (IKAP) 10-Day exponential moving average is 13.56, while Aurinia Pharmaceuticals’s (IKAP) share price is €13.53, making it a Sell.
Aurinia Pharmaceuticals’s (IKAP) 100-Day exponential moving average is 13.39, while Aurinia Pharmaceuticals’s (IKAP) share price is €13.53, making it a Sell.
Aurinia Pharmaceuticals’s (IKAP) stock price is €13.53 and Aurinia Pharmaceuticals’s (IKAP) 50-day simple moving average is 13.75, creating a Sell signal.
Aurinia Pharmaceuticals’s (IKAP) stock price is €13.53 and Aurinia Pharmaceuticals’s (IKAP) 100-day simple moving average is 13.37, creating a Sell signal.
Aurinia Pharmaceuticals’s (IKAP) stock price is €13.53 and Aurinia Pharmaceuticals’s (IKAP) 200-day simple moving average is 12.85, creating a Buy signal.

Aurinia Pharmaceuticals (IKAP) Technical Indicators

Jul 26, 2026, 01:47 PM
Name
Value
Implied Action
RSI (14)
41.44
Neutral
STOCH (9,6)
9.10
Buy
STOCHRSI (14)
9.10
Buy
MACD (12,26)
-0.17
Buy
ADX (14)
15.27
Buy
Williams %R
-100.00
Buy
CCI (14)
-129.04
Buy
ATR (14)
0.32
-
Ultimate Oscillator
40.40
Neutral
ROC
-4.12
Sell
Aurinia Pharmaceuticals’s (IKAP) Relative Strength Index (RSI) is 41.44, creating a Neutral signal.
Aurinia Pharmaceuticals’s (IKAP) Trend Strength Indicator (ADX) is 15.27, creating a Buy signal.
Aurinia Pharmaceuticals’s (IKAP) Commodity Channel Index (CCI) is -129.04, creating a Buy signal.
Aurinia Pharmaceuticals’s (IKAP) Price Rate of Change (ROC) is -4.12, creating a Sell signal.

FAQ

Is IKAP a Buy, Hold, or Sell?
Based on IKAP’s technical indicators, IKAP is a Sell.
    What is IKAP’s RSI (14)?
    IKAP’s RSI (14) is 41.44, which suggests IKAP is a Neutral.
      What is IKAP’s MACD?
      IKAP’s MACD is -0.17, which suggests IKAP is a Buy.
        What is IKAP’s 5-day moving average?
        IKAP’s 5-day moving average is 13.41, which suggests IKAP is a Sell.
          What is IKAP’s 20-day moving average?
          IKAP 20-day moving average is 13.85, which suggests IKAP is a Sell.
            What is IKAP’s 50-day moving average?
            IKAP’s 50-day moving average is 13.75, which suggests IKAP is a Sell.
              What is IKAP’s 200-day moving average?
              IKAP’s 200-day moving average is 12.85, which suggests IKAP is a Buy.
                What is IKAP’s Williams % R (14)?
                IKAP’s Williams % R (14) is -100.00, which suggests IKAP is a Buy.
                  What is IKAP’s CCI (14)?
                  IKAP’s CCI (14) is -129.04, which suggests IKAP is a Buy.
                    What is the share price of Aurinia Pharmaceuticals?